Mechanism is seductive. A clean molecular story this drug hits this enzyme, therefore it prevents this complication is satisfying to teach and easy to believe.
The familiar glucose lowering drug may also have an underappreciated anti-dicarbonyl footprint. The evidence is compelling, but the mechanism deserves an honest caveat. Enrique C.